ReviewBioengineering & translational medicine2026

Bridging the gap in OA therapeutics: Bioengineered strategies to target osteoclast-chondrocyte crosstalk.

Enbo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.